Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bydureon
Bydureon
5 Drugmakers Headed Back to the Drawing Board
Motley Fool
Mon, 01/31/11 - 06:54 pm
Bydureon
Eli Lilly
Amylin
diabetes
MannKind
Afrezza
InterMune
Esbriet
IPF
Lorqess
Arena Pharmaceuticals
Vivus
Qnexa
Timing Positive For Bydureon
Forbes
Wed, 01/26/11 - 08:38 pm
Bydureon
FDA
Amylin
QT intervals
Lilly Diabetes Drug Setbacks May Spur Biotech Shopping Spree Beyond Amylin
Bloomberg
Fri, 10/22/10 - 07:26 am
diabetes
Amylin
Eli Lilly
Cephalon
M&A
Endo
Bydureon
Byetta
What Amylin's Diabetes Treatment Complete Response Letter Means for Avanir
Seeking Alpha
Thu, 10/21/10 - 11:07 am
Amylin
diabetes
Alkermes
Eli Lilly
Bydureon
Amylin, Lilly, Alkermes Shares Slump as FDA Rejects Bydureon Diabetes Drug
Bloomberg
Wed, 10/20/10 - 10:46 am
Amylin
Eli Lilly
Alkermes
FDA
Bydureon
diabetes
One More Reason That Lilly Must Do A Deal, Fast
Pharmalot
Wed, 10/20/10 - 09:32 am
Eli Lilly
M&A
Amylin
Bydureon
diabetes
Alkermes
Alkermes' Drug Approval On Tap
Investors.com
Tue, 10/19/10 - 10:28 pm
Alkermes
FDA
Bydureon
diabetes
Eli Lilly
Amylin
Byetta
Vivitrol
alcoholism
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tue, 10/12/10 - 11:26 am
Linjeta
Biodel
Afrezza
MannKind
FDA
Benlysta
Human Genome
GSK
Bydureon
Eli Lilly
Amylin
Alkermes
Brilinta
AstraZeneca
Pradaxa
Boehringer Ingelheim
Qnexa
Vivus
Contrave
Orexigen
ipilimumab
Bristol-Myers Squibb
Merck KGaA
cladribine
It's All About the Future for Amylin
Motley Fool
Thu, 07/22/10 - 03:49 pm
Amylin
Bydureon
Byetta
diabetes
Novo Nordisk
Victoza
Merck
Januvia
Takeda
Actos
Onglyza
AstraZeneca
Amylin's New Diabetes Drug Well Tolerated By Sufferers
CNBC
Mon, 06/28/10 - 02:59 pm
Amylin
diabetes
Bydureon
type 2 diabetes
Eli Lilly's New Diabetes Drug
Yahoo/CNBC
Sat, 06/26/10 - 09:26 am
Eli Lilly
Bydureon
Byetta
Amylin Soars on Roche’s Diabetes Delay
Barron's
Sat, 06/19/10 - 12:55 pm
Amylin
Roche
type 2 diabetes
Bydureon
Amylin Drug Fails To Beat Generic
Forbes
Tue, 06/15/10 - 12:36 pm
generics
Amylin
metformin
diabetes
Bydureon
Byetta
Eli Lilly
BYDUREON™ FDA Review Timeline Set With PDUFA Action Date Of October 22, 2010
Medical News Today
Sun, 05/9/10 - 12:49 pm
Bydureon
Amylin
Eli Lilly
Alkermes
type 2 diabetes
Pages
« first
‹ previous
1
2
3